Gilead Sciences Gains an Opportunity for Immune System Reset With $1.7B Ouro Acquisition
Gilead Sciences is buying Ouro Medicines, a startup creating T cell engagers for a variety of autoimmune illnesses. Individually, Gilead ...
Gilead Sciences is buying Ouro Medicines, a startup creating T cell engagers for a variety of autoimmune illnesses. Individually, Gilead ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.